4572 — Carna Biosciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Carna Biosciences, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,207	1,133	2,018	1,387	1,626
Cost of Revenue
Gross Profit	3,000	941	1,882	1,215	1,451
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,274	2,216	2,558	2,701	2,747
Operating Profit	934	-1,082	-541	-1,314	-1,122
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	913	-1,102	-532	-1,323	-1,131
Provision for Income Taxes
Net Income After Taxes	828	-1,111	-534	-1,350	-1,153
Net Income Before Extraordinary Items
Net Income	828	-1,111	-534	-1,350	-1,153
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	828	-1,111	-534	-1,350	-1,153
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	78.1	-89	-41.6	-97	-68.4
Dividends per Share